53 research outputs found
Hospitalization and emergency department visits among seniors receiving homecare: a pilot study
BACKGROUND: Despite the recent growth in home health services, data on clinical outcomes and acute health care utilization among older adults receiving homecare services are sparse. Obtaining such data is particularly relevant in Ontario where an increasing number of frail seniors receiving homecare are awaiting placement in long-term care facilities. In order to determine the feasibility of a large-scale study, we conducted a pilot study to assess utilization of acute health care services among seniors receiving homecare to determine associated clinical outcomes. METHODS: This prospective cohort study followed forty-seven seniors admitted to homecare by two homecare agencies in Hamilton, Ontario over a 12-month period. Demographic information and medical history were collected at baseline, and patients were followed until either termination of homecare services, death, or end of study. The primary outcome was hospitalization. Secondary outcomes included emergency department visits that did not result in hospitalization and death. Rates of hospitalization and emergency department visits without admission were calculated, and univariate analyses were performed to test for potential risk factors. Survival curves for accumulative rates of hospitalization and emergency department visits were created. RESULTS: 312 seniors were eligible for the study, of which 123 (39%) agreed to participate initially. After communicating with the research nurse, of the 123 who agreed to participate initially, 47 (38%) were enrolled in the study. Eleven seniors were hospitalized during 3,660 days of follow-up for a rate of 3.0 incident hospitalizations per 1,000 homecare-days. Eleven seniors had emergency department visits that did not result in hospitalization, for a rate of 3.3 incident emergency department visits per 1,000 homecare-days. There were no factors significantly associated with hospitalization or emergency department visits when adjustment was made for multiple comparisons. CONCLUSION: The incidence of hospitalization and visits to the emergency department among seniors receiving homecare services is high. Getting satisfactory levels of enrolment will be a major challenge for larger prospective studies
Recommendations for enterovirus diagnostics and characterisation within and beyond Europe.
Enteroviruses (EV) can cause severe neurological and respiratory infections, and occasionally lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in Europe. However, these infections are still often underdiagnosed and EV typing data is not currently collected at European level. In order to improve EV diagnostics, collate data on severe EV infections and monitor the circulation of EV types, we have established European non-polio enterovirus network (ENPEN). First task of this cross-border network has been to ensure prompt and adequate diagnosis of these infections in Europe, and hence we present recommendations for non-polio EV detection and typing based on the consensus view of this multidisciplinary team including experts from over 20 European countries. We recommend that respiratory and stool samples in addition to cerebrospinal fluid (CSF) and blood samples are submitted for EV testing from patients with suspected neurological infections. This is vital since viruses like EV-D68 are rarely detectable in CSF or stool samples. Furthermore, reverse transcriptase PCR (RT-PCR) targeting the 5'noncoding regions (5'NCR) should be used for diagnosis of EVs due to their sensitivity, specificity and short turnaround time. Sequencing of the VP1 capsid protein gene is recommended for EV typing; EV typing cannot be based on the 5'NCR sequences due to frequent recombination events and should not rely on virus isolation. Effective and standardized laboratory diagnostics and characterisation of circulating virus strains are the first step towards effective and continuous surveillance activities, which in turn will be used to provide better estimation on EV disease burden
The effects of integrated care: a systematic review of UK and international evidence
BACKGROUND: Healthcare systems around the world have been responding to the demand for better integrated models of service delivery. However, there is a need for further clarity regarding the effects of these new models of integration, and exploration regarding whether models introduced in other care systems may achieve similar outcomes in a UK national health service context. METHODS: The study aimed to carry out a systematic review of the effects of integration or co-ordination between healthcare services, or between health and social care on service delivery outcomes including effectiveness, efficiency and quality of care. Electronic databases including MEDLINE; Embase; PsycINFO; CINAHL; Science and Social Science Citation Indices; and the Cochrane Library were searched for relevant literature published between 2006 to March 2017. Online sources were searched for UK grey literature, and citation searching, and manual reference list screening were also carried out. Quantitative primary studies and systematic reviews, reporting actual or perceived effects on service delivery following the introduction of models of integration or co-ordination, in healthcare or health and social care settings in developed countries were eligible for inclusion. Strength of evidence for each outcome reported was analysed and synthesised using a four point comparative rating system of stronger, weaker, inconsistent or limited evidence. RESULTS: One hundred sixty seven studies were eligible for inclusion. Analysis indicated evidence of perceived improved quality of care, evidence of increased patient satisfaction, and evidence of improved access to care. Evidence was rated as either inconsistent or limited regarding all other outcomes reported, including system-wide impacts on primary care, secondary care, and health care costs. There were limited differences between outcomes reported by UK and international studies, and overall the literature had a limited consideration of effects on service users. CONCLUSIONS: Models of integrated care may enhance patient satisfaction, increase perceived quality of care, and enable access to services, although the evidence for other outcomes including service costs remains unclear. Indications of improved access may have important implications for services struggling to cope with increasing demand. TRIAL REGISTRATION: Prospero registration number: 42016037725
Toward the integrated marine debris observing system
Plastics and other artificial materials pose new risks to the health of the ocean. Anthropogenic debris travels across large distances and is ubiquitous in the water and on shorelines, yet, observations of its sources, composition, pathways, and distributions in the ocean are very sparse and inaccurate. Total amounts of plastics and other man-made debris in the ocean and on the shore, temporal trends in these amounts under exponentially increasing production, as well as degradation processes, vertical fluxes, and time scales are largely unknown. Present ocean circulation models are not able to accurately simulate drift of debris because of its complex hydrodynamics. In this paper we discuss the structure of the future integrated marine debris observing system (IMDOS) that is required to provide long-term monitoring of the state of this anthropogenic pollution and support operational activities to mitigate impacts on the ecosystem and on the safety of maritime activity. The proposed observing system integrates remote sensing and in situ observations. Also, models are used to optimize the design of the system and, in turn, they will be gradually improved using the products of the system. Remote sensing technologies will provide spatially coherent coverage and consistent surveying time series at local to global scale. Optical sensors, including high-resolution imaging, multi- and hyperspectral, fluorescence, and Raman technologies, as well as SAR will be used to measure different types of debris. They will be implemented in a variety of platforms, from hand-held tools to ship-, buoy-, aircraft-, and satellite-based sensors. A network of in situ observations, including reports from volunteers, citizen scientists and ships of opportunity, will be developed to provide data for calibration/validation of remote sensors and to monitor the spread of plastic pollution and other marine debris. IMDOS will interact with other observing systems monitoring physical, chemical, and biological processes in the ocean and on shorelines as well as the state of the ecosystem, maritime activities and safety, drift of sea ice, etc. The synthesized data will support innovative multi-disciplinary research and serve a diverse community of users
Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines.
While wild type polio has been nearly eradicated there will be a need to continue immunisation programmes for some time because of the possibility of re-emergence and the existence of long term excreters of poliovirus. All vaccines in current use depend on growth of virus and most of the non-replicating (inactivated) vaccines involve wild type viruses known to cause poliomyelitis. The attenuated vaccine strains involved in the eradication programme have been used to develop new inactivated vaccines as production is thought safer. However it is known that the Sabin vaccine strains are genetically unstable and can revert to a virulent transmissible form. A possible solution to the need for virus growth would be to generate empty viral capsids by recombinant technology, but hitherto such particles are so unstable as to be unusable. We report here the genetic manipulation of the virus to generate stable empty capsids for all three serotypes. The particles are shown to be extremely stable and to generate high levels of protective antibodies in animal models
Stabilisation of virus particles reduces infectivity.
<p>Different numbers and combinations of the stabilising mutations described in Tables <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006117#ppat.1006117.t001" target="_blank">1</a> & <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006117#ppat.1006117.t003" target="_blank">3</a>, as well as others identified in similar ways, were introduced into capsid-coding sequences of infectious clones. HEp2c cells were transfected with infectious RNA transcripts and incubated at 37°C until 100% cytopathic effect (CPE) was observed, or frozen after 7 days if no CPE was apparent; clarified supernatants of these cell cultures were blind passaged into fresh HEp2c cells and cells incubated at 37°C until 100% CPE was observed or for a further 7 days. (A) type 1 Mahoney capsid mutants, (B) type 2 MEF-1 capsid mutants, (C) type 3 Leon capsid mutants. * no CPE observed after blind passage.</p
Thermostability of type 3 Leon particles.
<p>Reactivity of (A) virus and (B) empty capsid aliquots with MAb 520 and MAb 517 in ELISA after incubation at different temperatures for 10’. MAb 520 is specific for D Antigen and MAb 517 is specific for C Antigen.</p
Long-term stability of virus and empty capsid preparations compared to the IPV reference.
<p>Proportion of D antigen reactivity remaining after incubation at 37°C relative to incubation at 4°C. Aliquots of IPV, virus and empty capsid samples were incubated at 37°C and samples were removed at intervals and analysed by D Antigen ELISA; reactivity is expressed relative to samples incubated at 4°C for the same period. (A) Type 1, (B) Type 2, (C) Type 3.</p
Mutations included in capsid stabilised mutants for further study: Mahoney-SC7, MEF-SC5a and Saukett-SC8.
<p>Mutations included in capsid stabilised mutants for further study: Mahoney-SC7, MEF-SC5a and Saukett-SC8.</p
Recommended from our members
Poliovirus-spectfic CD4 + Thl Clones with Both Cytotoxic and Helper Activity Mediate Protective Humoral Immunity against a Lethal Poliovirus Infection in Transgenic Mice Expressing the Human Poliovirus Receptor
The current understanding of the function of CD4 + T helper (Th) cells in immunity to
infectious diseases is that Thl cells, which secrete interleukin (IL)-2 and interferon-3,, induce
cellular immune responses, whereas Th2 cells, which secrete IL-4, IL-5, IL-6, and IL-10, provide
helper function for humoral immunity. We have used a panel of poliovirus-specific murine
CD4 + T cell clones and mice transgenic for the human poliovirus receptor to evaluate the role
of Th cell subpopulations in protective immunity to poliovirus. The majority of T cell clones,
as well as polyclonal T cells generated from mice infected or immunized with poliovirus, secreted
IL-2 and interferon-q,, but not IL-4, IL-5, or IL-10, a profile typical of Thl cells. The Thl clones
displayed major histocompatibility complex class II-restricted cytotoxic T lymphocyte activity
against specific poliovirus peptide-pulsed target ceils, but also provided help for antipoliovirus
neutralizing antibody production. To examine the mechanism of immunity in vivo, we have
used poliovirus receptor-transgenic mice on a BALB/c (H-2 a) background. These animals
developed a poliomyelitis-like disease when challenged intravenously with a virulent wild-type
strain of poliovirus, but not with an attenuated vaccine strain. Furthermore, mice immunized
with the vaccine strain were protected against a subsequent challenge with wild-type virus. Using
an adoptive transfer technique, we demonstrated that it was possible to confer protection with
primed B cells in the presence of polyclonal poliovirus-specific T cells, but not when transgenic
mice received either B cells or T cells alone. Furthermore, protection was observed when mice
received primed B cells in the presence of a VP4-specific Thl clone. The findings demonstrate
that Thl cells can mediate a protective immune response against poliovirus infection in vivo
through helper activity for humoral immunity and that CD4 § T cells, specific for the internal
poliovirus capsid protein, VP4, can provide effective help for a protective antibody response directed
against surface capsid proteins
- …